The market moved up Thursday, and Nifty 50 ended at 23852 points, which is an increase of 1.8 percent. The index has not closed higher since Jan 3. The index has now closed up for the fourth day in a row and this past week the index has gained as much as 5.8 percent. The index triggered a buy signal by the break up through the resistance at 23641 points in inverse head and shoulders formation. A further increase to 25385 points within four months is indicated. 818 shares showed a gain and 493 showed a loss. 12 shares were unchanged and closed at the same price as the previous day. There was no trading in 12 shares. Total value of the trading volume for shares and primary capital certificates Thursday was approximately 770.1 billion. | |
Fertilizers and Chemicals | 13.82% |
Oswal Agro Mills Ltd. | 13.11% |
SMS Lifesciences India Ltd | 13.02% |
Ashima Limited | 12.93% |
Libas Designs Ltd. | 11.36% |
Akme Fintrade India Ltd | -88.76% |
Rossell India Limited | -6.14% |
Dynemic Products Ltd. | -6.08% |
Sonata Software Limited | -6.07% |
Kesoram Industries Limited | -5.12% |
HDFC Bank Limited | 34037.54 |
ICICI Bank Limited | 24603.78 |
State Bank of India | 21558.92 |
Bharti Airtel Limited | 20580.47 |
Infosys Limited | 20248.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.